Literature DB >> 20543760

An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features.

Min-Shi Lee1, Tzou-Yien Lin, Pai-Shan Chiang, Wen-Chen Li, Shu-Ting Luo, Kuo-Chien Tsao, Guan-Yuan Liou, Mei-Liang Huang, Shao-Hsuan Hsia, Yhu-Chering Huang, Shih-Cheng Chang.   

Abstract

BACKGROUND: Enterovirus 71 (EV71) is causing life-threatening hand-foot-mouth disease in Asia. In Taiwan, EV71 epidemics with different predominant genotypes occurred in 1998 (C2), 2000-2001 (B4), and 2004-2005 (C4). This genotype replacement may have important implications for vaccine development and prediction of epidemics. A nationwide EV71 outbreak occurred again in 2008, which provided a unique opportunity to characterize clinical, virologic, and serologic features of this epidemic.
METHODS: We analyzed clinical and virologic data of 111 EV71 patients hospitalized in 2008 and prospectively conducted follow-ups of healthy children from June 2006 to December 2008.
RESULTS: Among the 111 EV71 inpatients, 21 (19%) developed complications. Among the 21 complicated cases, 15 had central nervous system complication only, 2 had acute heart failure, and 4 had central nervous system and pulmonary complications. In the prospective study, 11 symptomatic infections and 4 asymptomatic infections were detected. Twenty-two EV71 isolates were genotyped, and 21 of them belong to genotype B5, which is phylogenetically close to B5 viruses circulating in Southeast Asia. Serologic tests show that children infected with B5 viruses have lower geometric mean titers of neutralizing antibody against genotype C4 than those against genotype B5 (P = 0.004, t test).
CONCLUSIONS: The 2008 nationwide EV71 epidemic was caused by genotype B5 that was likely introduced to Taiwan from Southeast Asia. Clinical features of the 2008 epidemic were not different from those observed before in Taiwan. Potential antigenic variations between genotype C4 and B5 viruses could be detected and its long-term epidemiologic significance needs further investigation to clarify.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20543760     DOI: 10.1097/INF.0b013e3181e52945

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  32 in total

1.  A case-control study of risk factors for severe hand-foot-mouth disease in Yuxi, China, 2010-2012.

Authors:  Ze Liu; Shukun Wang; Rusong Yang; Xia Ou
Journal:  Virol Sin       Date:  2014-04       Impact factor: 4.327

2.  Fluoxetine is a potent inhibitor of coxsackievirus replication.

Authors:  Jun Zuo; Kevin K Quinn; Steve Kye; Paige Cooper; Robert Damoiseaux; Paul Krogstad
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

Review 3.  Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.

Authors:  Bingyi Yang; Peng Wu; Joseph T Wu; Eric H Y Lau; Gabriel M Leung; Hongjie Yu; Benjamin J Cowling
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

4.  Latitude-based approach for detecting aberrations of hand, foot, and mouth disease epidemics.

Authors:  Jia-Hong Tang; Ta-Chien Chan; Mika Shigematsu; Jing-Shiang Hwang
Journal:  BMC Med Inform Decis Mak       Date:  2015-12-24       Impact factor: 2.796

5.  Cell surface vimentin is an attachment receptor for enterovirus 71.

Authors:  Ning Du; Haolong Cong; Hongchao Tian; Hua Zhang; Wenliang Zhang; Lei Song; Po Tien
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

6.  Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China.

Authors:  Yong Zhang; Jitao Wang; Wanshen Guo; Haiyan Wang; Shuangli Zhu; Dongyan Wang; Ruyin Bai; Xingle Li; Dongmei Yan; Huiling Wang; Yan Zhang; Zhen Zhu; Xiaojuan Tan; Hongqiu An; Aiqiang Xu; Wenbo Xu
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

7.  Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09.

Authors:  Min-Shi Lee; Pai-Shan Chiang; Shu-Ting Luo; Mei-Liang Huang; Guan-Yuan Liou; Kuo-Chien Tsao; Tzou-Yien Lin
Journal:  PLoS Negl Trop Dis       Date:  2012-02-14

Review 8.  Challenges to licensure of enterovirus 71 vaccines.

Authors:  Min-Shi Lee; Fan-Chen Tseng; Jen-Ren Wang; Chia-Yu Chi; Pele Chong; Ih-Jen Su
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28

9.  Comparing molecular methods for early detection and serotyping of enteroviruses in throat swabs of pediatric patients.

Authors:  Pai-Shan Chiang; Mei-Liang Huang; Shu-Ting Luo; Tzou-Yien Lin; Kuo-Chien Tsao; Min-Shi Lee
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

10.  Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.

Authors:  Mei-Liang Huang; Pai-Shan Chiang; Min-Yuan Chia; Shu-Ting Luo; Luan-Yin Chang; Tzou-Yien Lin; Mei-Shang Ho; Min-Shi Lee
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.